Webinar Objectives: 

• Define and categorize transfusion reactions
• Describe clinical manifestations of specific transfusion reactions
• Discuss patient evaluation and management when transfusion reactions is suspected

Speaker: Margo R Rollins, MD 

Webinar Objectives: 

• Define transfusion-related acute lung injury (TRALI) and the role of HLA antibodies in TRALI
• Describe the properties of HLA antibodies and how these properties are incorporated into TRALI mitigated strategies
• Review the incidence, potential causes, and differential diagnosis of TRALI
• Discuss the current AABB standards and recommendations related to the prevention, reduction, and investigation of TRALI
• Discuss HLA Antibody testing methods and TRALI reduction program at Rhode Island Blood Center

Speakers: Dr. Massimo Mangiola  Christine Beritela, MS, MT(ASCP)SBB

Webinar Objectives: 

• Define Pretransfusion Testing
• Recognize the Pretransfusion Processing Steps
• Identify the Purpose of the Crossmatch Test
• Recognize Characteristics of Serologic and Computer Crossmatch Methoids

Webinar Objectives: 

• Define Direct Antiglobulin Tests (DATs)
• Recognize Applications of the DAT
• Identify Reagents used in the DAT
• Interpret DAT Results

Webinar Objectives: 

• Hospitals and Blood Donar systems
• Blood Banks and Blood Transfusion
• Patient testing in Blood Banks
• Safe Blood Transfusion
• Blood Collection

Webinar Objectives: 

• Background
• Transfusion Service Activity
• Evolution in Technology
• ABO titration for IgM Anti-A & Anti-B in full automation
• Platelet Deficiency  - HIT
•  Thrombosis and Thrombocytopenia

Speaker: Susanna Bresciani   Silvia Ferrari 

Webinar Objectives: 

• Importance and significance in continuing education initiatives within the blood banking community

Speaker: Jay Slayten MS, MT(ASCP)SBB

Webinar Objectives: 

• What is and Red Blood Cell (RBC) and What is its importance
• RBC Critical Functions
• RBC Lifecycle and Membrane Structure
• Antigens on Membrane Surface

Webinar Objectives: 

• Describe the functions of enzymes on red blood cells
• Compare enzyme treatment to chemical treatment
• Discuss the use of enzyme treated red blood cells in antibody detection and identification pathways

Speaker: Tricia Sanders 

Webinar Objectives: 

• Discuss and interpret interactive immunohematology case studies

Speaker: Monica Kalvelage

Webinar Objectives: 

• Review the scope of BeadChip PreciseType^@ testing
• Discuss published indications for RBC genotyping in patients
• Describe Northwestern Memorial Hospital approach
• Examine benefits of DNA phenotyping in subsequent workups
• Discuss questions and comments

Speaker: Glenn Ramsey

Webinar Objectives:

• Review RBC alloimmunization persistence despite advances in serologic testing
• Discuss limitations of serological testing
• PreciseType@ HEA RBC genetic  testing helps overcome these limitations
• Clinical applications
• Questions and Answers

Speaker: Cassandra Josephson

Webinar Objectives: 

• Describe the application of molecular testing in the hospital donor center and transfusion service
• Discuss the impact of molecular testing on serologic antibody identification workups through case studies
• List the benefits of leveraging software to simultaniously view serology and molecular testing

Speakers: Jessie Singer MT (ASCP)  Cassandra Josephson MD

Webinar Objectives: 

• Define Monocyte Monolayer Assay (MMA) and determine when it should be considered
• Understand the role of molecular testing in the blood bank
• Evaluate the application of MMA and molecular testing using a case study approach

Speaker: Katrina Bilingsley

Webinar Objectives: 

• Brazilian experience and clinical benefits of blood group genotyping in patents with SCD and thalassemia
• Molecular matching
• RH genotyping in patients with SCD and donors

Speaker: Connie Westhoff, PhD

Webinar Objectives: 

• Introduction to Blood Bank basics
• Discuss limitations of serologic phenotyping
• Description of RBC molecular typing and potential advantages over serologic typing
• Application of RBC molecular typing

Speaker: Ross M Fasano

Webinar Objectives: 

• Echo improvements and their benefits
• ImmuLINK

Speaker: Nancy Harrison 

Webinar Objectives: 

• ImmuLINK function and capabilities
• Hamilton Regional Library medicine program
• CoLabs and ImmuLINK

Speaker: Sandra Fazari MLT, BSC, MBA 

Webinar Objectives: 

• ImmuLINK background
• ImmuLINK demonstration

Speaker: Giuffre Gianni 

Webinar Objectives: 

• ABO Blood group systems
• How does FDA impact ABO Blood groups
• History of blood transfusion
• Landsteiner's Law

Webinar Objectives: 

• Explain the formation of H, A, and B antigens and soluble substances
• Interpret ABO typing results including ABO discrepancy testing
• Discuss ABO antibodies including immunoglobulin classes and the importance of reverse testing

Speaker: Tricia Sanders

Webinar Objectives: 

• Discuss the testing methodologies used for antigen typing
• Differentiate between monoclonal and polyclonal antisera
• Explain the importance of phenotyping in antibody identification
• Describe common antigen typing protocols for multiply transfused patients

Speaker: Trica Sanders

Webinar Objectives: 

• Outline the steps involved in the recognition and evaluation of a transfusion reaction
• Classify non-infections transfusion reactions
• Discuss the factors that contribute to the pathophysiology of febrile non-hemolytic transfusion reactions
• Explain the pathophysiological mechanisms involved in immune-mediated hemolysis and how the pro-inflammatory environment is responsible for many of the signs and symptoms related to a hemolytic reaction
• Describe the various factors that influence the development of alloimmunization to RBC antigens

Speaker: Diana L. Riddle, MT, SBB(ASCP)CM

Webinar Objectives

• Distinguish immune response into the action of T Cells and B Cells.
• Recognize the role of immunoglobulins and cells involved in primary and secondary immune response.
• Outline function and process of complement activation in transfusion medicine.
• Demonstrate genetic concepts of blood groups exploring pedigree analysis and population genetics.

Speaker: Jayanna Slayten MS, MT(ASCP)SBB

Webinar Objectives: 

• Discuss the advantages of implementing HIT screening tests into your facility

Speaker: Kerry Dowling